首页> 外文期刊>Acta oncologica. >Postoperative radiotherapy in DBCG during 30 years. Techniques, indications and clinical radiobiological experience.
【24h】

Postoperative radiotherapy in DBCG during 30 years. Techniques, indications and clinical radiobiological experience.

机译:在DBCG中进行30年的术后放疗。技术,适应症和临床放射生物学经验。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

During the time period 1977-2007 postoperative radiotherapy in DBCG has varied considerably with regard to techniques and indications together with changes in the extent of surgery and adjuvant systemic therapy. The radiation treatment has been developed on the basis of clinical, radiophysical and radiobiological principles, encompassing also practical problems such as available equipment in the different centres and at times lack of sufficient machine capacity. The paper focus especially on the comprehensive work done prior to the DBCG 82 b&c studies, in order to optimize radiotherapy in all aspects prior to the evaluation of the efficacy of this treatment modality. The results from these trials did succeed in clear evidence that radiotherapy has an important role in the multidisciplinary treatment of early breast cancer. In parallel to these studies a new and challenging use of radiotherapy after breast conserving surgery was evaluated in the DBCG TM 82 protocol. The experience obtained with different techniques in this study formed the basis for the current principles of radiotherapy after lumpectomy. Reduction of radiation related morbidity has been a major issue for the DBCG radiotherapy group, and in this aspect several studies, including quality control visits, have been carried out to make the relevant modifications and to evaluate deviations from the guidelines between the centres. The background for the changes in radiotherapy is described for each of the programme periods as well as future perspectives which will include further refinements of the target and adjustments of dose and fractionation in selected patients.
机译:在1977-2007年期间,DBCG的术后放疗在技术和适应症以及手术和辅助全身治疗的范围方面发生了很大变化。放射治疗是根据临床,放射物理和放射生物学原理开发的,还包括一些实际问题,例如不同中心的可用设备,有时缺乏足够的机器能力。这篇论文特别着重于DBCG 82 b&c研究之前所做的全面工作,以便在评估这种治疗方式的疗效之前在各个方面优化放疗。这些试验的结果确实获得了明确的证据,证明放疗在早期乳腺癌的多学科治疗中具有重要作用。与这些研究并行,在DBCG TM 82方案中评估了保乳手术后放射疗法的一种新的挑战性应用。在这项研究中使用不同技术获得的经验为目前进行的肿块切除术后放疗原则奠定了基础。减少与辐射有关的发病率一直是DBCG放射治疗小组的主要问题,在这一方面,已经进行了包括质量控制访问在内的多项研究,以进行相关修改并评估中心之间的指南偏差。针对每个计划阶段以及未来的前景,介绍了放疗变化的背景,其中包括对目标的进一步细化以及对选定患者的剂量和分级的调整。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号